Ellen D Yorke

Author PubWeight™ 35.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010 4.33
2 Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 2010 2.32
3 Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk? Int J Radiat Oncol Biol Phys 2008 2.20
4 Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys 2010 2.14
5 Measurement of lung tumor motion using respiration-correlated CT. Int J Radiat Oncol Biol Phys 2004 1.74
6 The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. Int J Radiat Oncol Biol Phys 2010 1.65
7 The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys 2012 1.46
8 Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. Int J Radiat Oncol Biol Phys 2010 1.44
9 The CT motion quantitation of lung lesions and its impact on PET-measured SUVs. J Nucl Med 2004 1.44
10 Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 2002 1.41
11 A method for evaluating quality assurance needs in radiation therapy. Int J Radiat Oncol Biol Phys 2008 1.22
12 The atlas of complication incidence: a proposal for a new standard for reporting the results of radiotherapy protocols. Semin Radiat Oncol 2006 1.18
13 Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer. Int J Radiat Oncol Biol Phys 2012 1.17
14 Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2002 1.12
15 Intensity-modulated radiotherapy. Cancer J 2002 1.07
16 Recommendations for clinical electron beam dosimetry: supplement to the recommendations of Task Group 25. Med Phys 2009 0.96
17 Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT). Radiat Oncol 2013 0.95
18 (18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 2008 0.86
19 Investigation of gated cone-beam CT to reduce respiratory motion blurring. Med Phys 2013 0.84
20 Intensity-modulated radiotherapy as the boost or salvage treatment of nasopharyngeal carcinoma: the appropriate parameters in the inverse planning and the effect of patient's anatomic factors on the planning results. Radiother Oncol 2005 0.84
21 Stereotactic body radiation therapy for primary lung cancers >3 centimeters. J Thorac Oncol 2013 0.83
22 Evaluation of tumor motion effects on dose distribution for hypofractionated intensity-modulated radiotherapy of non-small-cell lung cancer. J Appl Clin Med Phys 2010 0.80
23 Accurate positioning for head and neck cancer patients using 2D and 3D image guidance. J Appl Clin Med Phys 2010 0.79
24 Methodology for biologically-based treatment planning for combined low-dose-rate (permanent implant) and high-dose-rate (fractionated) treatment of prostate cancer. Int J Radiat Oncol Biol Phys 2005 0.78
25 Failure patterns relative to radiation treatment fields for stage II-IV thymoma. J Thorac Oncol 2014 0.77
26 Toward correcting drift in target position during radiotherapy via computer-controlled couch adjustments on a programmable Linac. Med Phys 2013 0.77
27 Geometric dose prediction model for hemithoracic intensity-modulated radiation therapy in mesothelioma patients with two intact lungs. J Appl Clin Med Phys 2016 0.77
28 Using generalized equivalent uniform dose atlases to combine and analyze prospective dosimetric and radiation pneumonitis data from 2 non-small cell lung cancer dose escalation protocols. Int J Radiat Oncol Biol Phys 2012 0.75
29 The role of external beam in brachytherapy. Future Oncol 2007 0.75